Genetic markers of bevacizumab-induced hypertension

Diether Lambrechts; Matthieu Moisse; Paul Delmar; David W. Miles; Natasha B. Leighl; Bernard Escudier; Eric Van Cutsem; Aruna T. Bansal; Peter Carmeliet; Stefan Scherer; Sanne de Haas; Céline Pallaud

doi:10.1007/s10456-014-9424-7

Article2011

Genetic Markers in Relation to Bevacizumab-induced Hypertension

Diether Lambrechts, D.W. Miles, N Leight, Leonard B. Saltz, B. Escudier, Eric Van Cutsem, Aruna T. Bansal, S.J. Scherer, Peter Carmeliet, Sanne de Haas

Article2011

1412 POSTER Genetic Markers in Relation to Bevacizumab-induced Hypertension

Diether Lambrechts, D.W. Miles, N. B. Leighl, Leonard B. Saltz, Bernard Escudier, Eric Van Cutsem, Abhishek Bansal, S.J. Scherer, Peter Carmeliet, Sanne de Haas

Article2013

Markers of Response for the Antiangiogenic Agent Bevacizumab

Diether Lambrechts, Heinz‐Josef Lenz, Sanne de Haas, Peter Carmeliet, Stefan Scherer

Article1984

Genetic Markers in Renal Adenocarcinoma

Anastasios E. Germenis, Meletios A Dimopoulos, A Fertakis, C Dimopoulos

Article1984

Genetic Markers in Carcinoma of the Prostate

Anastasios E. Germenis, P Savides, A. Karayanis, A Fertakis, C. Dimopoulos, Meletios A Dimopoulos

Genetic markers of bevacizumab-induced hypertension

Discussion(0)

Related publications

Genetic Markers in Relation to Bevacizumab-induced Hypertension

1412 POSTER Genetic Markers in Relation to Bevacizumab-induced Hypertension

Markers of Response for the Antiangiogenic Agent Bevacizumab

Genetic Markers in Renal Adenocarcinoma

Genetic Markers in Carcinoma of the Prostate